Robert Roswell Chai-Onn, EVP, General Couns. & Corporate Secretary at Valeant Pharmaceuticals International, Inc. (VRX), sold 10,203 shares at $121.70 ($1.2M) on 2014-06-23, disclosed to the SEC on 2014-06-24.
Scheduled sale ($1.2M) by EVP, General Couns. & Corporate Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRX | SELL | 2014-05-14 | $1.3M | — | Filing → |
| VRX | SELL | 2014-03-19 | $709K | — | Filing → |
| VRX | BUY | 2013-08-23 | $500K | — | Filing → |